AIDS Weekly articles from November 2004

AIDS Weekly archives from November 2004

Study identifies target for preventing sexual transmission of HIV.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have shown that it may be possible to block male-to-female HIV transmission in heterosexual intercourse and have identified the target for blocking that transmission. Their findings...

HIV-1 non-B subtypes from heterosexual transmission predominate in Scotland.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- HIV-1 non-B subtypes acquired from heterosexual transmissions predominate in Scotland. According to a study from Scotland, "Historically, subtype B viruses in men who have sex with men (MSM) and...

Dying cells drive the capacity of HIV-1 to kill noncycling primary CD4+ cells.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Dying, neighboring cells drive the capacity of HIV-1 to kill noncycling primary CD4+ cells. According to recent research published in the journal Cell Death and Differentiation, "CD4+ T-cell death...

Host cell gene expression varies during HIV-1 latency or reactivation.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The host cell gene expression varies during HIV-1 latency or reactivation. "The existence of reservoirs of cells latently infected with human immunodeficiency virus (HIV) is a major obstacle to the...

HIV-1 gp120-induced nitric oxide increases proinflammatory cytokines.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- HIV-1 gp120-induced nitric oxide increases proinflammatory cytokines. "It has become clear that spinal cord glia (microglia and astrocytes) importantly contribute to the creation of exaggerated pain...

HIV-1 superinfections assessed by autologous heteroduplex mobility.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Scientists have assessed HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso by an autologous heteroduplex mobility procedure. In a recently published article, scientists in...

Current state of HIV and AIDS in Sub-Saharan Africa reviewed.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers review the current state of AIDS and HIV in Sub-Saharan Africa in a recent issue of the Croatian Medical Journal. According to a study from Malawi and the United States, "Sub-Saharan...

HIV-1 immunogen vaccine plus antiretrovirals promotes virologic control.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Therapeutic immunization with an inactivated HIV-1 immunogen plus antiretrovirals promotes virologic control in asymptomatic HIV-infected subjects. According to a study from Spain, "To determine...

In Soweto, South Africa, transactional sex may increase women's risk of HIV.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- According to recent research from the United States, "Sex workers have long been considered a high-risk group for HIV infection, but to date little quantitative research has explored the association...

Genetics products company named to Technology Fast 50 Program for Washington.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corporation (TGEN) has been named to Deloitte's Technology Fast 50 Program for Washington State, a ranking of the 50 fastest growing technology companies in the area by Deloitte &...

Swedish company presents mass screening tests at investment conference.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Swedish blood diagnostics company LifeAssays Inc. presented its mass screening and point-of-care tests on Oct. 21 at the Windhover Information and Medtech Insight's "Investment In Innovation" Event, at...

Chiron announces blood-screening licensing agreement.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) has granted a nonexclusive license to the blood transfusion centers of the German Red Cross (Blutspendediensten des Deutsche Rotes Kreuz, or DRK) for use of the company's HIV-1 and...

Company changes name and prepares for HIV vaccine trial.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Research company Merix Bioscience announced the change of its name to Argos Therapeutics, Inc. Additionally, the company stated that it is preparing for an HIV clinical trial with Argos' proprietary...

HIV infection increases risk of dental caries in children.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- HIV infection increases the risk of dental caries in children. "The interrelationship of HIV infection, dental caries, and mucosal immune responses remains controversial. In our study population of...

HIV diagnostic proves effective in Dominican Republic trials.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Medical Services International (MSITF) announced that it has completed a series of testing of its VScan HIV 1&2 rapid test kit in the Dominican Republic, and the results showed 100% accuracy in terms of...

Chinese CDC attends HIV/AIDS training seminar.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Diagnostic test developer MedMira Inc. (MMIRF) announced a series of technical training seminars in collaboration with the Centers for Disease Control (CDC) in the People's Republic of China. These...

Immune restoration disease arises in association with antiretroviral therapy.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Immune restoration disease arises in association with antiretroviral therapy. "Suppression of human immunodeficiency virus (HIV) replication by highly active antiretroviral therapy (HAART) often...

In Zimbabwe, hair salons promote female condom use to protect against HIV.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Besides styling hair, Zimbabwean hairdressers are now making waves by promoting the female condom as a protective device against HIV/AIDS, reports the UN Integrated Regional Information Networks (IRIN;...

Older women's knowledge of HIV is lacking, study finds.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Age is no defense against AIDS. Women aged 50 and older are living longer and remain sexually active, yet many lack appropriate knowledge about HIV transmission and prevention, according to recent...

Biotechnology company files a request of re-examination of Benitec.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Nucleonics, Inc., announced that it has filed with the U.S. Patent and Trademark Office (PTO) a request for re-examination of Benitec and the Australian Commonwealth Scientific and Industrial Research...

Diagnostics firm secured new funding to develop new sensor technology.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Diagnostic systems developer LabNow, Inc., announced that it has raised $14 million in equity financing from a syndicate of private and venture investors led by George Soros, with the participation of...

Biopharma company intends to continue development of treatment for Cachexia.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- PhytoMedical Technologies, Inc., (OTCBB:PYTO) announced its intention to continue development of its proprietary "BDC-03" compound, targeting Cachexia - a gravely deteriorating "human wasting" condition...

South Africa needs more nurses as HIV/AIDS infections among healthcare workers rise.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A study by a South African medical journal warned that the country needs more nurses as the number HIV/AIDS infections rises among healthcare workers. The report published in the October edition of...

'Green Arrow' comic to feature HIV-positive sidekick.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Along with fighting alien menaces and criminal masterminds, the "Green Arrow" comic book will now feature a sidekick engaged in a more personal struggle, this one against HIV. It's the first major...

New lead in quest to protect women from sexual HIV transmission.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Scientists have long sought a vaginal gel that women could apply before sex to block the AIDS virus. Now they've found a new lead, a chemical specially designed to thwart the way HIV penetrates women's...

Peer program teaches inmates about HIV/AIDS.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Harold Omar Hill has a method to persuade new prisoners at David Wade Correctional Center in Louisiana, to take an HIV test. "If you're sick inside a prison, you'll do hard, hard time," the...

Primary hotline questions in Netherlands regard HIV transmission/risk/testing.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Primary AIDS hotline questions in the Netherlands regard HIV transmission, HIV risk and HIV testing. According to recent research from the Netherlands, "AIDS telephone hotlines have an important...

U.N. warns Africa to brace itself for the AIDS time bomb.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Africa must brace itself for an AIDS time bomb as 8,000 people are infected with HIV a day in the region worst hit by the pandemic, the United Nations warned. Seventy percent of the 45 million...

APOBEC3G incorporated into HIV-1 virions through viral/nonviral RNA interactions.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- APOBEC3G is incorporated into HIV-1 virions through viral and nonviral RNA interactions. "Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is a host cytidine deaminase...

Antisense U7 snRNAs and siRNAs targeting cyclophilin A inhibit HIV-1 replication.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Antisense U7 snRNAs and siRNAs targeting cyclophilin A inhibit HIV-1 replication. According to published research from Switzerland, "Human immunodeficiency virus 1 (HIV-1) multiplication depends on...

HIV-1 infectivity enhanced by forming particle-mediated syncytia in CD4+ cells.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- HIV-1 infectivity is enhanced by forming particle-mediated syncytia in CD4+ cells. According to published research from Japan, "The infection and subsequent replication rates of human...

Memantine protects hippocampal neuronal function in HIV-1 encephalitis.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Memantine protects hippocampal neuronal function in HIV-1 encephalitis. "Memantine, a low-to-moderate-affinity NMDA receptor antagonist, can be used to treat cognitive impairment associated with...

R5 HIV-1 replicates more efficiently in primary CD4+ cells than X4 HIV-1.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- R5 HIV-1 replicates more efficiently in primary CD4+ cells than X4 HIV-1. According to recent research from the United States, "In this report, we present evidence that R5 human immunodeficiency...

Structure of initiation complex of HIV-1 reverse transcription is not conserved.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The structure of the initiation complex of HIV-1 reverse transcription is not conserved. According to a study from France, "HIV-1 reverse transcription is initiated from a tRNA(3)(Lys) molecule...

TSG101 mutations that inhibit PTAP or VPS28 binding block HIV-1 budding.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- TSG101 mutations that inhibit PTAP or VPS28 binding block HIV-1 budding. "Efficient human immunodeficiency virus type 1 (HIV-1) budding requires an interaction between the PTAP late domain in the...

Tumorigenesis by HHV-8 chemokine receptor vGPCR is accelerated by HIV-1 Tat.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Tumorigenesis by the HHV-8 chemokine receptor vGPCR is accelerated by HIV-1 Tat. According to a study from the United States, "Human herpesvirus 8 (HHV-8), also called Kaposi's sarcoma (KS)...

CD4+ cell non-production during HAART due to inefficiencies at multiple steps.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- CD4+ cell non-production during highly active antiretroviral therapy is due to inefficiencies at multiple steps. "A stable latent reservoir for human immunodeficiency virus type 1 (HIV-1) in...

Critical reporting elements for quality of study methods reported.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Scientists have outlined critical reporting elements for quality of study methods in individual- and group-level HIV intervention research in a recent issue of AIDS Education and Prevention. "To...

Jury is still out regarding benefits of switching to protease-sparing regimen.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The jury is still out regarding the benefits of switching to a protease-sparing regimen. According to a recently published review in the Journal of Antimicrobial Chemotherapy, "Body fat changes and...

Nevirapine is better than efavirenz at raising "good" cholesterol.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Two of the most commonly prescribed drugs for treating HIV - nevirapine and efavirenz - can both raise levels of the "good type" of cholesterol (HDL cholesterol), but nevirapine raises it higher than...

Africans give their governments poor marks on evaluation.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Africans gave their governments poor marks in a landmark scorecard on the way officials run 28 of the continent's nations, a senior U.N. official said. Corruption, poor tax systems and dilapidated...

Former Maryland Governor wants public registry for people with AIDS.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Maryland should establish a public registry for people with AIDS to help stop its spread because "other methods of prevention aren't working," Comptroller William Donald Schaefer said. "People...

HIV-positive Russians detained during protest in western city.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- About a dozen HIV-positive Russians were detained in the western city of Kaliningrad after chaining themselves to the city hall building to protest the state's alleged failure to provide them with...

Private clinics in South Africa urge drug companies to lower prices.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A U.S. AIDS foundation appealed to large drug manufacturers not to raise the price of AIDS drugs when incorporating new South African pricing regulations. Michael Weinstein, president of the AIDS...

Sadness still rules at Thai AIDS hospice, but now there is also some hope.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The Wat Pra Baht Nam Phu Thailand hospice smells of death. Each morning as nurses check patients and help gather soiled bed linen, attendants wearing green plastic gloves, rubber boots and surgical...

Study: Fuzeon plus active boosted PI doubles long-term response.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Twice as many treatment-experienced patients who used Fuzeon (enfuvirtide) with an active boosted protease inhibitor (PI) regimen experienced a significant virologic response when compared to patients...

CCR5-targeted SIV vaccination strategy prevents or inhibits SIV.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- CCR5-targeted SIV vaccination strategy prevented or inhibited SIV infection. "Cell-surface CCR5 is a major coreceptor with CD4 glycoprotein, mediating cellular entry of CCR5 strains of HIV-1 or SIV...

New PAHO fact sheets on HIV reflect differences in cost, care, coverage.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The Pan American Health Organization (PAHO) issued reports on the first 7 of 47 countries and territories with new and specific data on the care and treatment of people with HIV in the Americas. They...

Drug development company announces hepatitis C study presented at conference.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Debiopharm S.A. announced that, Jan Paeshuyse and Johan Neyts, associate professor, from the Belgian Rega Institute presented data on the potent and selective inhibition effect of DEBIO-025 on the...

Persistence of hepatitis C virus associated with human leukocyte antigen class 1.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Persistence of hepatitis C virus is associated with human leukocyte antigen class 1. According to recent research published in the journal Human Immunology, "The aim of this study was to define...

FDA grants priority review to Pegasys with Copegus for HCV in HIV patients.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has granted 6-month priority review status to the supplemental new biologics license application (sBLA) for Roche's combination therapy of Pegasys...

Isolated case of pulmonary KS in pregnancy reported.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Physicians at Northwestern University's Feinberg School of Medicine have described the first reported case of isolated pulmonary Kaposi's sarcoma in pregnancy. "Kaposi's sarcoma in human...

Defendant in Olympia HIV assault case waives jury trial.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A man charged with exposing 27 women to the virus that causes AIDS and with trying to talk some out of testifying against him has waived a Washington State jury trial. Instead, Thurston County...

Government marijuana? No thanks, say Dutch, "coffee" shop pot will do fine.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- There's a whiff of crisis in the air at the Dutch Health Ministry: It's sitting on a pile of pot that it just can't sell. The Netherlands rolled out a program last year that allows patients to buy...

LEDGF/p75 is a component of functional lentiviral preintegration complexes.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Transcriptional coactivator LEDGF/p75 is a component of functional lentiviral preintegration complexes. According to recent research from the United States, "Human immunodeficiency virus type 1...

New patient dies at Los Angeles hospital after nurse fails to check on him.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A nurse turned down an audio alarm on a vital-signs monitor and then failed to notice when a 28-year-old AIDS patient went into cardiac distress and died, California county health officials said. ...

Update provided on revised Oxygent development plan.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Alliance Pharmaceutical Corp. (ALLP) announced that it has received clarification from the European Agency for the Evaluation of Medical Products (EMEA) regarding development recommendations for Oxygent...

Strategies addressed to discourage brain drain of international scientists.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Strategies have been addressed to discourage brain drain of international scientists. "Building health research expertise in developing countries often requires personnel to receive training beyond...

Highly infectious SARS-CoV reveals cell tropism/receptor expression correlation.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Highly infectious SARS-CoV pseudotypes reveals cell tropism and receptor expression correlation. According to a study from China, "Studies of SARS coronavirus (SARS-CoV)-the causative agent of...

Interactive video behavioral intervention reduces adolescent females' STD risk.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A study from the United States found that an interactive video behavioral intervention reduced adolescent females' risk of acquiring a sexually transmitted disease (STD). J.S. Downs at Carnegie...

U.S. government agency awards global TB drug development group $8 million grant.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The United States Agency for International Development (USAID) announced an $8 million grant to the Global Alliance for TB Drug Development (TB Alliance) for research and development into new drugs to...

HSP70 domains stimulate cytokines and chemokines.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Functional domains of heat shock protein 70 (HSP70) stimulate generation of cytokines and chemokines, maturation of dendritic cells and adjuvanticity. According to published research from England...

More than 250 global leaders endorse U.N. women's rights agenda.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- More than 250 global leaders in all fields, including 85 heads of state and government, have signed a statement endorsing a U.N. plan adopted 10 years ago to ensure every woman's right to education,...

Cobas Amplicor HIV Monitor 1.5 test modified to measure proviral DNA in PBMCs.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- The Cobas Amplicor HIV Monitor 1.5 test was modified to measure proviral DNA in peripheral blood mononuclear cells. "Recent studies have suggested that monitoring the amount of HIV provirus in...

Primary drug resistance persists in recently HIV-1 infected adults.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Primary drug resistance persists in recently HIV-1 infected adults. "Primary, or transmitted, drug resistance is common among treatment naive patients recently infected with HIV-1, and impairs...

HAART interruptions have a negative effect on CD4 cell increase.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Highly active antiretroviral treatment interruptions have a negative effect on CD4 cell increase in HIV infection. According to a study from Belgium, "Our objective was to study the evolution of...

Imperatorin inhibits HIV-1 replication through Sp1-dependent pathway.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. "Coumarins and structurally related compounds have been recently shown to present anti-human immunodeficiency virus, type 1...

Co-infection with HIV and malaria in pregnant women remains a challenge.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- There is more to learn regarding treatment of pregnant women co-infected with HIV and malaria, researchers say. According to recent research published in the American Journal of Tropical Medicine...

Temporal trends in HIV-1 epidemic in Russia reported.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Investigators report temporal trends in the HIV-1 epidemic in Russia in a recent issue of the Journal of Medical Virology. According to a study from Russia, "During the period 1996-1997, three...

HDAC inhibitors reactivate HIV-1 expression in cellular reservoirs.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Administration of HDAC inhibitors reactivate HIV-1 expression in latent cellular reservoirs. "The discovery of powerful antiviral compounds in the 90's raised the hope that the human...

Macaques infected with attenuated SIV remain resistant to challenge.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant...

ART drugs pose potential cancer hazard to exposed children.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- According to recent research from the United States, "The current worldwide spread of the human immunodeficiency virus-1 (HIV-1) to the heterosexual population has resulted in approximately 800,000...

HAART changes hepatitis B and C viremia in patients coinfected with HIV.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- HAART changes hepatitis B and C viremia in patients coinfected with HIV. "Chronic infection with either hepatitis B (HBV) or hepatitis C virus (HCV) is frequently present in patients seropositive...

Oxidative stress and caspase activation involved in paclitaxel-induced apoptosis.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Oxidative stress and caspase activation are involved in paclitaxel-induced apoptosis. According to a study from Taiwan, "Paclitaxel has significant antitumor activity in several human tumors,...

Fuzeon awarded 2004 International Prix Galien for most innovative new medicine.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- HIV drug Fuzeon (enfuvirtide or T-20) was awarded the 2004 International Prix Galien for the most innovative new medicine. Fuzeon was selected out of 12 major new drugs in all therapeutic areas...

Hospital interpreters break language barriers.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- The information Maria del Carmen Cepeda received from postpartum nurse Malinda Lawson was basic. But the new mother doesn't speak English and might have had a much harder time understanding Lawson...

Gene-identification company provides 2004 update.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Enzo Biochem, Inc., (ENZ), a biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, reported operating...

Licensing agreement signed with Ani Biotech.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corporation (HIV) announced that it has entered into a worldwide licensing technology transfer and equipment purchase agreement with Ani Biotech (Ani). The agreement grants...

Caribbean distributor orders second round of HIV diagnostic kits.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Diagnostics company MedMira (MMIRF) announced that it has received a second order from its Caribbean distributor, Caribbean Medical Inc. (CMI), for MedMira's MiraWell3 Rapid (HBV/HIV/HCV) Triple Test....

Rapid diagnostic test kits used in Caribbean and China.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Medical Services International announced that as a result of the excellent test results from the Dominican Republic, it has received an endorsement from the Institute of Virology. According to...

ARV resistance mutations directly related to length and type of prior treatment.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- ARV resistance mutations are directly related to the length and type of prior treatment. "We determined the prevalence of antiretroviral (ARV) resistance in HIV-1 infected indigent persons in San...

Researchers push the envelope to overcome HIV/AIDS drug resistance.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- The evolution of resistance to currently prescribed HIV-1 protease inhibitors is devastating to patients and is surprising given the way these drugs work. Protease inhibitors are all...

Immunotherapy shows early success against Epstein-Barr virus-associated tumors.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Immunotherapy shows early success against Epstein-Barr virus-associated tumors. "Epstein-Barr Virus (EBV) is associated with a number of tumors, including lymphomas in solid organ transplant (SOT)...

Dutch biotech reports increased Q3 revenues.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Dutch biotechnology company Crucell, NV, (CRXL) announced its financial results for the third quarter of 2004. Crucell reports revenues of EUR 4.1 million (US$5.1 million) for the third quarter...